Supply Chain Management Part 2: Creating a Logistics Strategy for Commercialization

With the increased focus on cell and gene therapies as potentially curative therapies, critical developments in supply chain strategy are required to enable efficient and seamless delivery to patients. The second part of the Supply Chain Management series addresses:

  • Logistical considerations and challenges at the point of care, including package and shipping qualification, process qualification, storage equipment validation and storage infrastructure requirements.
  • Novel approaches for end-to-end product tracking and management of data across the supply chain.
  • Developments in Point of Care Manufacturing - can ‘GMP in a box’ be achieved for autologous therapies?
  • Latest advances in cold chain technologies and cryopreservation – the potential impact of freeze-thawing cycles on product viability; PoC handling and training requirements.